Le Lézard
Classified in: Business, Covid-19 virus
Subject: SBS

Globalization Partners to Credit Clients With Australia Cash Flow Boost


BOSTON, April 29, 2020 /PRNewswire/ -- Globalization Partners, which enables companies to hire and retain global team members without setting up complex international legal infrastructures, today announced it will issue a payroll credit to clients who have team members on the Globalization Partners' payroll in Australia. The payouts are a result of the Australian government's Boosting Cash Flow for Employers Measure.

This support has been initiated by the Australian government to provide a temporary cash flow boost to small and medium businesses with an annual turnover of up to AUD 50M to ease their financial stress due to the COVID-19 pandemic. Eligible businesses will receive between AUD 20,000 to AUD 100,000 from the government based on the size of their payroll withholding in two payments:

Globalization Partners has received the first boost payment of AUD 50,000 and will be crediting this amount to its clients with team members in Australia. In addition, the company is expecting to receive the second boost payment of AUD 50,000 between June and September 2020 and will issue that credit to clients upon receipt.

"We know this is a challenging time for our clients and our team has been actively monitoring government assistance and relief programs to businesses around the world to determine the applicability and required qualifications," said Nicole Sahin, CEO of Globalization Partners. "We are pleased to announce the payout of these funds to help ease some of the financial stress for our clients and the professionals we employ on their behalf in Australia."

Globalization Partners understands that having the right support can make an enormous difference in helping companies successfully navigate the challenges associated with COVID-19. Please click here to learn about free support services that Globalization Partners is providing to its customers and prospective clients. For more information on everything from individual country updates to practical advice about working remotely please visit: COVID-19 Your Global Team is Our Priority.

About Globalization Partners
Globalization Partners enables companies to quickly and easily expand internationally across six continents and into more than 170 countries without the hassle of setting up local branch offices or subsidiaries. It allows companies to hire employees throughout the world without having to navigate complex international legal, tax, and HR issues. You identify the talent, and we put your team member on our payroll. Whether it's to test a new market or expand your talent pool, Globalization Partners is the most trustworthy solution in the market. We have dual U.S. headquarters to serve you in Boston and San Diego, and regional hub offices located worldwide in the UK, Germany, the UAE, India, Shanghai, Singapore, Brazil, and Mexico.

Globalization Partners is Privacy Shield certified for HR Data. To find out more, please visit: globalization-partners.com or connect with us via Twitter, LinkedIn, Facebook, or check out our Blog.

Contact:
Karen Pantinas
[email protected] 
617-729-4466

SOURCE Globalization Partners


These press releases may also interest you

at 05:45
The Gross Law Firm issues the following notice to shareholders of Amplitude, Inc. . Shareholders who purchased shares of AMPL during...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 05:30
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...



News published on and distributed by: